Key Financial Inc’s TG Therapeutics TGTX Stock Holding History

Key Financial Inc’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110K	Hold	2,000	–	–	0.02%	404
2026 Q1	$66.4K	Hold	2,000	–	–	0.01%	478
2025 Q4	$59.6K	Hold	2,000	–	–	0.01%	481
2025 Q3	$73.1K	Hold	2,000	–	–	0.01%	448
2025 Q2	$72K	Hold	2,000	–	–	0.01%	425
2025 Q1	$78.9K	Hold	2,000	–	–	0.02%	398
2024 Q4	$60.2K	Hold	2,000	–	–	0.01%	446
2024 Q3	$46.8K	Hold	2,000	–	–	0.01%	489
2024 Q2	$35.6K	Hold	2,000	–	–	0.01%	526
2024 Q1	$30.4K	Hold	2,000	–	–	0.01%	528
2023 Q4	$34.2K	Hold	2,000	–	–	0.01%	491
2023 Q3	$16.7K	Hold	2,000	–	–	0.01%	604
2023 Q2	$49.7K	Hold	2,000	–	–	0.02%	409
2023 Q1	$30.1K	Hold	2,000	–	–	0.01%	463
2022 Q4	$11.8K	Hold	2,000	–	–	0.01%	592
2022 Q3	$12K	Hold	2,000	–	–	0.01%	596
2022 Q2	$9K	Hold	2,000	–	–	﹤0.01%	665
2022 Q1	$19K	Hold	2,000	–	–	0.01%	517
2021 Q4	$38K	Hold	2,000	–	–	0.02%	386
2021 Q3	$67K	Hold	2,000	–	–	0.04%	298
2021 Q2	$70K	Hold	2,000	–	–	0.04%	293
2021 Q1	$96K	Hold	2,000	–	–	0.06%	199
2020 Q4	$104K	Buy	+2,000	New	+$67.6K	0.08%	178
2020 Q2	–	Sell	-2,000	Closed	-$21K	–	571
2020 Q1	$21K	Buy	+2,000	New	+$25.3K	0.02%	319

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Key Financial Inc's TGTX Position: Q2 2026 in Review

Key Financial Inc held its TG Therapeutics (TGTX) position steady in Q2 2026 at 2,000 shares worth $110K. The position accounts for 0.02% of the portfolio, ranked #404.

Key Financial Inc first reported a position in TGTX in Q1 2020 and has held it in 24 quarters since. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Key Financial Inc held 2,000 shares of TG Therapeutics worth $110K as of Q2 2026.
Key Financial Inc left its TG Therapeutics share count unchanged in Q2 2026.
TG Therapeutics made up 0.02% of Key Financial Inc's portfolio in Q2 2026, its #404 holding.
Key Financial Inc first reported a position in TG Therapeutics in Q1 2020 and has held it in 24 quarters since.
430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.